APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mealtime Insulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mealtime Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchMealtime Insulin Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Mealtime Insulin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Mealtime Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mealtime Insulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mealtime Insulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Mealtime Insulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mealtime Insulin include Abbott Laboratories, BASF, Biocon Biologics, Gan & Lee Pharmaceuticals, Novo Nordisk, Wockhardt, Bayer, HTBT and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mealtime Insulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mealtime Insulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mealtime Insulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mealtime Insulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Mealtime Insulin Segment by Company

Abbott Laboratories

BASF

Biocon Biologics

Gan & Lee Pharmaceuticals

Novo Nordisk

Wockhardt

Bayer

HTBT

Pfizer

Sinovac Biotech

Eli Lilly

Sanofi

Tonghua Dongbao Pharmaceutical

Wanbang Biopharmaceuticals

Zhuhai United Pharmaceutical

Mealtime Insulin Segment by Type

Rapid-acting Insulin Analogs

Short-acting Insulin

Mealtime Insulin Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Mealtime Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mealtime Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mealtime Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mealtime Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mealtime Insulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mealtime Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mealtime Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mealtime Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mealtime Insulin Industry Trends Table 2. Mealtime Insulin Industry Drivers Table 3. Mealtime Insulin Industry Opportunities and Challenges Table 4. Mealtime Insulin Industry Restraints Table 5. Global Mealtime Insulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mealtime Insulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mealtime Insulin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Mealtime Insulin Sales Market Share by Manufacturers Table 9. Global Mealtime Insulin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mealtime Insulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mealtime Insulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mealtime Insulin Manufacturers, Product Type & Application Table 13. Global Mealtime Insulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mealtime Insulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rapid-acting Insulin Analogs Table 17. Major Manufacturers of Short-acting Insulin Table 18. Global Mealtime Insulin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 20. Global Mealtime Insulin Sales by Type (2027-2032) & (K Units) Table 21. Global Mealtime Insulin Sales Market Share by Type (2021-2026) Table 22. Global Mealtime Insulin Sales Market Share by Type (2027-2032) Table 23. Global Mealtime Insulin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Mealtime Insulin Revenue by Type (2021-2026) & (K Units) Table 25. Global Mealtime Insulin Revenue by Type (2027-2032) & (K Units) Table 26. Global Mealtime Insulin Revenue Market Share by Type (2021-2026) Table 27. Global Mealtime Insulin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Mealtime Insulin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 33. Global Mealtime Insulin Sales by Application (2027-2032) & (K Units) Table 34. Global Mealtime Insulin Sales Market Share by Application (2021-2026) Table 35. Global Mealtime Insulin Sales Market Share by Application (2027-2032) Table 36. Global Mealtime Insulin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Mealtime Insulin Revenue by Application (2021-2026) & (K Units) Table 38. Global Mealtime Insulin Revenue by Application (2027-2032) & (K Units) Table 39. Global Mealtime Insulin Revenue Market Share by Application (2021-2026) Table 40. Global Mealtime Insulin Revenue Market Share by Application (2027-2032) Table 41. Global Mealtime Insulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Mealtime Insulin Sales by Region (2021-2026) & (K Units) Table 43. Global Mealtime Insulin Sales Market Share by Region (2021-2026) Table 44. Global Mealtime Insulin Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Mealtime Insulin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 48. North America Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 49. Europe Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 51. Europe Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 58. Global Mealtime Insulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Mealtime Insulin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Mealtime Insulin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Mealtime Insulin Revenue Market Share by Region (2021-2026) Table 62. Global Mealtime Insulin Revenue Market Share by Region (2027-2032) Table 63. Abbott Laboratories Company Information Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Laboratories Mealtime Insulin Product Portfolio Table 67. Abbott Laboratories Recent Development Table 68. BASF Company Information Table 69. BASF Business Overview Table 70. BASF Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BASF Mealtime Insulin Product Portfolio Table 72. BASF Recent Development Table 73. Biocon Biologics Company Information Table 74. Biocon Biologics Business Overview Table 75. Biocon Biologics Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biocon Biologics Mealtime Insulin Product Portfolio Table 77. Biocon Biologics Recent Development Table 78. Gan & Lee Pharmaceuticals Company Information Table 79. Gan & Lee Pharmaceuticals Business Overview Table 80. Gan & Lee Pharmaceuticals Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio Table 82. Gan & Lee Pharmaceuticals Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novo Nordisk Mealtime Insulin Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Wockhardt Company Information Table 89. Wockhardt Business Overview Table 90. Wockhardt Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Wockhardt Mealtime Insulin Product Portfolio Table 92. Wockhardt Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bayer Mealtime Insulin Product Portfolio Table 97. Bayer Recent Development Table 98. HTBT Company Information Table 99. HTBT Business Overview Table 100. HTBT Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. HTBT Mealtime Insulin Product Portfolio Table 102. HTBT Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Mealtime Insulin Product Portfolio Table 107. Pfizer Recent Development Table 108. Sinovac Biotech Company Information Table 109. Sinovac Biotech Business Overview Table 110. Sinovac Biotech Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sinovac Biotech Mealtime Insulin Product Portfolio Table 112. Sinovac Biotech Recent Development Table 113. Eli Lilly Company Information Table 114. Eli Lilly Business Overview Table 115. Eli Lilly Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Eli Lilly Mealtime Insulin Product Portfolio Table 117. Eli Lilly Recent Development Table 118. Sanofi Company Information Table 119. Sanofi Business Overview Table 120. Sanofi Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sanofi Mealtime Insulin Product Portfolio Table 122. Sanofi Recent Development Table 123. Tonghua Dongbao Pharmaceutical Company Information Table 124. Tonghua Dongbao Pharmaceutical Business Overview Table 125. Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio Table 127. Tonghua Dongbao Pharmaceutical Recent Development Table 128. Wanbang Biopharmaceuticals Company Information Table 129. Wanbang Biopharmaceuticals Business Overview Table 130. Wanbang Biopharmaceuticals Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio Table 132. Wanbang Biopharmaceuticals Recent Development Table 133. Zhuhai United Pharmaceutical Company Information Table 134. Zhuhai United Pharmaceutical Business Overview Table 135. Zhuhai United Pharmaceutical Mealtime Insulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio Table 137. Zhuhai United Pharmaceutical Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Mealtime Insulin Distributors List Table 141. Mealtime Insulin Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Mealtime Insulin Product Image Figure 2. Global Mealtime Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mealtime Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Mealtime Insulin Sales (2021-2032) & (K Units) Figure 5. Global Mealtime Insulin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mealtime Insulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rapid-acting Insulin Analogs Image Figure 9. Short-acting Insulin Image Figure 10. Global Mealtime Insulin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Mealtime Insulin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mealtime Insulin Sales Market Share by Type (2021-2032) Figure 13. Global Mealtime Insulin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Mealtime Insulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mealtime Insulin Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Mealtime Insulin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Mealtime Insulin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Mealtime Insulin Sales Market Share by Application (2021-2032) Figure 22. Global Mealtime Insulin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Mealtime Insulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Mealtime Insulin Revenue Market Share by Application (2021-2032) Figure 25. North America Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 27. U.S. Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 32. Germany Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 39. China Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 47. Brazil Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Mealtime Insulin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Mealtime Insulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Mealtime Insulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Mealtime Insulin Revenue (2021-2032) & (US$ Million) Figure 58. North America Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Mealtime Insulin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mealtime Insulin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Mealtime Insulin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Mealtime Insulin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Mealtime Insulin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Rapid-acting Insulin Analogs
  • Short-acting Insulin
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Abbott Laboratories
  • BASF
  • Biocon Biologics
  • Gan & Lee Pharmaceuticals
  • Novo Nordisk
  • Wockhardt
  • Bayer
  • HTBT
  • Pfizer
  • Sinovac Biotech
  • Eli Lilly
  • Sanofi
  • Tonghua Dongbao Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Zhuhai United Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mealtime Insulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mealtime Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mealtime Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mealtime Insulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mealtime Insulin Market Dynamics
  1. 2.1 Mealtime Insulin Industry Trends
  2. 2.2 Mealtime Insulin Industry Drivers
  3. 2.3 Mealtime Insulin Industry Opportunities and Challenges
  4. 2.4 Mealtime Insulin Industry Restraints
3 Mealtime Insulin Market by Manufacturers
  1. 3.1 Global Mealtime Insulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mealtime Insulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mealtime Insulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mealtime Insulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mealtime Insulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mealtime Insulin Manufacturers, Product Type & Application
  7. 3.7 Global Mealtime Insulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mealtime Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mealtime Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mealtime Insulin Tier 1, Tier 2, and Tier 3
4 Mealtime Insulin Market by Type
  1. 4.1 Mealtime Insulin Type Introduction
  2. 4.1.1 Rapid-acting Insulin Analogs
  3. 4.1.2 Short-acting Insulin
  4. 4.2 Global Mealtime Insulin Sales by Type
  5. 4.2.1 Global Mealtime Insulin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mealtime Insulin Sales by Type (2021-2032)
  7. 4.2.3 Global Mealtime Insulin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mealtime Insulin Revenue by Type
  9. 4.3.1 Global Mealtime Insulin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mealtime Insulin Revenue by Type (2021-2032)
  11. 4.3.3 Global Mealtime Insulin Revenue Market Share by Type (2021-2032)
5 Mealtime Insulin Market by Application
  1. 5.1 Mealtime Insulin Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Mealtime Insulin Sales by Application
  6. 5.2.1 Global Mealtime Insulin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mealtime Insulin Sales by Application (2021-2032)
  8. 5.2.3 Global Mealtime Insulin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Mealtime Insulin Revenue by Application
  10. 5.3.1 Global Mealtime Insulin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mealtime Insulin Revenue by Application (2021-2032)
  12. 5.3.3 Global Mealtime Insulin Revenue Market Share by Application (2021-2032)
6 Global Mealtime Insulin Sales by Region
  1. 6.1 Global Mealtime Insulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mealtime Insulin Sales by Region (2021-2032)
  3. 6.2.1 Global Mealtime Insulin Sales by Region (2021-2026)
  4. 6.2.2 Global Mealtime Insulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mealtime Insulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mealtime Insulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mealtime Insulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mealtime Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mealtime Insulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mealtime Insulin Revenue by Region
  1. 7.1 Global Mealtime Insulin Revenue by Region
  2. 7.1.1 Global Mealtime Insulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mealtime Insulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Mealtime Insulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Mealtime Insulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mealtime Insulin Revenue (2021-2032)
  8. 7.2.2 North America Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mealtime Insulin Revenue (2021-2032)
  11. 7.3.2 Europe Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mealtime Insulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mealtime Insulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mealtime Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Mealtime Insulin Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 BASF
  8. 8.2.1 BASF Company Information
  9. 8.2.2 BASF Business Overview
  10. 8.2.3 BASF Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BASF Mealtime Insulin Product Portfolio
  12. 8.2.5 BASF Recent Developments
  13. 8.3 Biocon Biologics
  14. 8.3.1 Biocon Biologics Company Information
  15. 8.3.2 Biocon Biologics Business Overview
  16. 8.3.3 Biocon Biologics Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biocon Biologics Mealtime Insulin Product Portfolio
  18. 8.3.5 Biocon Biologics Recent Developments
  19. 8.4 Gan & Lee Pharmaceuticals
  20. 8.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 8.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 8.4.3 Gan & Lee Pharmaceuticals Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio
  24. 8.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 8.5 Novo Nordisk
  26. 8.5.1 Novo Nordisk Company Information
  27. 8.5.2 Novo Nordisk Business Overview
  28. 8.5.3 Novo Nordisk Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk Mealtime Insulin Product Portfolio
  30. 8.5.5 Novo Nordisk Recent Developments
  31. 8.6 Wockhardt
  32. 8.6.1 Wockhardt Company Information
  33. 8.6.2 Wockhardt Business Overview
  34. 8.6.3 Wockhardt Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wockhardt Mealtime Insulin Product Portfolio
  36. 8.6.5 Wockhardt Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Mealtime Insulin Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 HTBT
  44. 8.8.1 HTBT Company Information
  45. 8.8.2 HTBT Business Overview
  46. 8.8.3 HTBT Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HTBT Mealtime Insulin Product Portfolio
  48. 8.8.5 HTBT Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Mealtime Insulin Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Sinovac Biotech
  56. 8.10.1 Sinovac Biotech Company Information
  57. 8.10.2 Sinovac Biotech Business Overview
  58. 8.10.3 Sinovac Biotech Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sinovac Biotech Mealtime Insulin Product Portfolio
  60. 8.10.5 Sinovac Biotech Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Mealtime Insulin Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
  67. 8.12 Sanofi
  68. 8.12.1 Sanofi Company Information
  69. 8.12.2 Sanofi Business Overview
  70. 8.12.3 Sanofi Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi Mealtime Insulin Product Portfolio
  72. 8.12.5 Sanofi Recent Developments
  73. 8.13 Tonghua Dongbao Pharmaceutical
  74. 8.13.1 Tonghua Dongbao Pharmaceutical Company Information
  75. 8.13.2 Tonghua Dongbao Pharmaceutical Business Overview
  76. 8.13.3 Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio
  78. 8.13.5 Tonghua Dongbao Pharmaceutical Recent Developments
  79. 8.14 Wanbang Biopharmaceuticals
  80. 8.14.1 Wanbang Biopharmaceuticals Company Information
  81. 8.14.2 Wanbang Biopharmaceuticals Business Overview
  82. 8.14.3 Wanbang Biopharmaceuticals Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio
  84. 8.14.5 Wanbang Biopharmaceuticals Recent Developments
  85. 8.15 Zhuhai United Pharmaceutical
  86. 8.15.1 Zhuhai United Pharmaceutical Company Information
  87. 8.15.2 Zhuhai United Pharmaceutical Business Overview
  88. 8.15.3 Zhuhai United Pharmaceutical Mealtime Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio
  90. 8.15.5 Zhuhai United Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mealtime Insulin Value Chain Analysis
  2. 9.1.1 Mealtime Insulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mealtime Insulin Production Mode & Process
  6. 9.2 Mealtime Insulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mealtime Insulin Distributors
  9. 9.2.3 Mealtime Insulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst